Zurich Cantonal Bank’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Zurich Cantonal Bank’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-869	Closed	-$18K	–	2922
2022 Q3	$18K	Hold	869	–	–	﹤0.01%	2819
2022 Q2	$21K	Hold	869	–	–	﹤0.01%	2794
2022 Q1	$43K	Hold	869	–	–	﹤0.01%	2559
2021 Q4	$61K	Hold	869	–	–	﹤0.01%	2679
2021 Q3	$81K	Hold	869	–	–	﹤0.01%	2448
2021 Q2	$87K	Hold	869	–	–	﹤0.01%	2278
2021 Q1	$81K	Sell	869 -545	-39%	-$55.3K	﹤0.01%	2237
2020 Q4	$117K	Buy	+1,414	New	+$121K	﹤0.01%	2150

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Zurich Cantonal Bank's VBIV Position: Q4 2022 in Review

Zurich Cantonal Bank sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2022, closing a stake of 869 shares — an estimated $18K sold.

Zurich Cantonal Bank first reported a position in VBIV in Q4 2020 and held it in 8 quarters. The position peaked at $117K in Q4 2020. 112 funds tracked by Wall St. Rank hold VBIV as of Q4 2022.

Zurich Cantonal Bank reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2022 after selling out during the quarter.
Zurich Cantonal Bank sold 869 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2022, an estimated $18K.
Zurich Cantonal Bank first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2020 and held it in 8 quarters.
Zurich Cantonal Bank's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $117K in Q4 2020.
112 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2022.

Based on Zurich Cantonal Bank's 13F filing for Q4 2022, filed 1 Feb 2023.